Search - tctmd.com

Displaying 341 - 360 of 448

Sort: Relevancy | Date

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

Presentation TCT 2015

ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis

Presenter: Cindy L. Grines, Robert A. Byrne

October 14, 2015

Presentation TCT 2015

ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis

Presenter: Robert A. Byrne

October 14, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

Presentation TCT 2015

Cre8: Design, Current Status, and Future Directions

Presenter: Marie-Claude Morice, Leif Thuesen, Didier Carrié

October 12, 2015

Presentation TCT 2015

Drug-Filled Stent: Concept, Preclinical Studies, and Early Clinical Observations

Presenter: Marie-Claude Morice, Leif Thuesen, Stephen G. Worthley

October 12, 2015

Presentation TCT 2015

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

Presenter: Marie-Claude Morice, Leif Thuesen, Philip M. Urban

October 12, 2015

Presentation TCT 2015

BioFreedom I: Angiographic Results and Late Clinical Outcomes of the FIM Trial

Presenter: Marie-Claude Morice, Leif Thuesen, Christian M. Spaulding

October 12, 2015

Presentation TCT 2015

Spot Stenting and DCB Use: Rationale and Therapeutic Options

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Peter A. Schneider

October 12, 2015

Presentation TCT 2015

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

Presenter: John R. Laird Jr, Gunnar Tepe, Thomas Zeller

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

Presentation TCT 2015

Debate: For SFA Disease I Prefer a Drug-Coated Balloon With Provisional Bare-Metal Stenting

Presenter: Julie Logan, George L Adams

October 11, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

Advertisement

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis

ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

Cre8: Design, Current Status, and Future Directions

Drug-Filled Stent: Concept, Preclinical Studies, and Early Clinical Observations

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

BioFreedom I: Angiographic Results and Late Clinical Outcomes of the FIM Trial

Spot Stenting and DCB Use: Rationale and Therapeutic Options

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Debate: For SFA Disease I Prefer a Drug-Coated Balloon With Provisional Bare-Metal Stenting

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content